769 related articles for article (PubMed ID: 11824977)
21. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
[TBL] [Abstract][Full Text] [Related]
22. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
Defendenti C; Atzeni F; Spina MF; Grosso S; Cereda A; Guercilena G; Bollani S; Saibeni S; Puttini PS
Autoimmun Rev; 2011 Jan; 10(3):150-4. PubMed ID: 20854935
[TBL] [Abstract][Full Text] [Related]
23. [Quantification of SS-B autoantibodies in patient sera using highly purified human SS-B antigens and their clinical interpretation].
Pfeifle J; Wolff JM; Anderer FA; Franke M
Z Rheumatol; 1986; 45(6):296-303. PubMed ID: 3493602
[TBL] [Abstract][Full Text] [Related]
24. Sensitivity and specificity for primary Sjögren's syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA.
Ruffatti A; Ostuni P; Grypiotis P; Botsios C; Tonello M; Grava C; Favaro M; Todesco S
J Rheumatol; 2004 Mar; 31(3):504-7. PubMed ID: 14994395
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies to HMG-17 nucleosomal protein in patients with scleroderma.
Vlachoyiannopoulos PG; Boumba VA; Tzioufas AG; Seferiadis C; Tsolas O; Moutsopoulos HM
J Autoimmun; 1994 Apr; 7(2):193-201. PubMed ID: 8037838
[TBL] [Abstract][Full Text] [Related]
26. [Hemorheologic disturbances and circulating immune complexes in patients with rheumatic diseases].
Loskutova TT; Koreshkov GG; Nasonov EL; Zakharchenko VN; Larionov SM
Ter Arkh; 1989; 61(5):51-5. PubMed ID: 2781490
[No Abstract] [Full Text] [Related]
27. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F
Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies specific for alpha-enolase in systemic autoimmune disorders.
Pratesi F; Moscato S; Sabbatini A; Chimenti D; Bombardieri S; Migliorini P
J Rheumatol; 2000 Jan; 27(1):109-15. PubMed ID: 10648026
[TBL] [Abstract][Full Text] [Related]
29. Relationships between autoantibody responses to deletion mutants of Ki antigen and clinical manifestations of lupus.
Matsudaira R; Takeuchi K; Takasaki Y; Yano T; Matsushita M; Hashimoto H
J Rheumatol; 2003 Jun; 30(6):1208-14. PubMed ID: 12784391
[TBL] [Abstract][Full Text] [Related]
30. Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.
Bentow C; Swart A; Wu J; Seaman A; Manfredi M; Infantino M; Benucci M; Lakos G; Mahler M
Clin Chim Acta; 2013 Sep; 424():141-7. PubMed ID: 23727029
[TBL] [Abstract][Full Text] [Related]
31. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
Půtová I; Dostal C; Becvar R
Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to ribonucleic acids detected by ELISA in systemic lupus erythematosus, systemic sclerosis and rheumatoid arthritis.
Costa O; Pinatel K; Monier JC
J Rheumatol; 1985 Oct; 12(5):928-33. PubMed ID: 2418204
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneous nuclear RNPs as targets of autoantibodies in systemic rheumatic diseases.
Op De Beéck K; Maes L; Van den Bergh K; Derua R; Waelkens E; Van Steen K; Vermeersch P; Westhovens R; De Vlam K; Verschueren P; Hooijkaas H; Blockmans D; Bossuyt X
Arthritis Rheum; 2012 Jan; 64(1):213-21. PubMed ID: 21905010
[TBL] [Abstract][Full Text] [Related]
35. Anti-p53 antibodies are rarely detected in serum of patients with rheumatoid arthritis and Sjögren's syndrome.
Mariette X; Sibilia J; Delaforge C; Bengoufa D; Brouet JC; Soussi T
J Rheumatol; 1999 Aug; 26(8):1672-5. PubMed ID: 10451060
[TBL] [Abstract][Full Text] [Related]
36. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus.
Mansour RB; Lassoued S; Gargouri B; El Gaïd A; Attia H; Fakhfakh F
Scand J Rheumatol; 2008; 37(2):103-8. PubMed ID: 18415766
[TBL] [Abstract][Full Text] [Related]
37. Profiles of antibodies to histones, DNA and IgG in patients with systemic rheumatic diseases determined by ELISA.
Gripenberg M; Helve T; Kurki P
J Rheumatol; 1985 Oct; 12(5):934-9. PubMed ID: 3878880
[TBL] [Abstract][Full Text] [Related]
38. The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera.
Schett G; Rubin RL; Steiner G; Hiesberger H; Muller S; Smolen J
Arthritis Rheum; 2000 Feb; 43(2):420-8. PubMed ID: 10693884
[TBL] [Abstract][Full Text] [Related]
39. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
40. Autoantibodies to HMG-17 nucleosomal protein in autoimmune rheumatic diseases. Correlation with systemic lupus erythematosus clinical activity and with antibodies to double-stranded DNA.
Tzioufas AG; Boumba VA; Seferiadis K; Tsolas O; Moutsopoulos HM
Arthritis Rheum; 1993 Jul; 36(7):955-61. PubMed ID: 8318042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
